Anlotinib alone or in combination with temozolomide in recurrent high-grade glioma: A retrospective study.

被引：0
|
作者：
Yang, Qun-ying
Guo, Cheng-Cheng
He, Zhenqiang
Lin, Fuhua
Zhang, Ji
Guo, Xiaoyu
Chen, Yinsheng
Jiang, Xiaobing
Ke, Chao
Chen, Zhongping
Mou, Yonggao
机构：
[1] Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Neurosurg Neuro Oncol, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ Canc Ctr, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Univ Canc Ctr, Canc Ctr, Dept Neurosurg Neurooncol, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e14019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14019
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis
    Yang, Qunying
    Guo, Chengcheng
    Lin, Xiaoping
    Luo, Lili
    He, Zhenqiang
    Lin, Fuhua
    Zhang, Ji
    Chen, Yinsheng
    Jiang, Xiaobing
    Ke, Chao
    Mou, Yonggao
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [2] Anlotinib as Monotherapy or Combination Therapy for Recurrent High-Grade Glioma: A Retrospective Study
    Yin, Jun
    Yin, Wenya
    Zheng, Linlin
    Li, Yimin
    Luo, Cheng
    Zhang, Shuo
    Duan, Lei
    Zhou, Hang
    Cheng, Kai
    Lang, Jinyi
    Xu, Ke
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2023, 17
  • [3] Temozolomide for recurrent high-grade glioma
    Macdonald, DR
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 3 - 12
  • [4] A phase II study of anlotinib in the treatment of recurrent high-grade glioma
    Dai, H.
    Zhang, M.
    Zhang, Q.
    Zhao, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S521 - S522
  • [5] A phase II study of anlotinib in the treatment of recurrent high-grade glioma: Updated results
    Dai, H.
    Zhang, M.
    Zhao, S.
    Zhang, Q.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S676 - S677
  • [6] Temozolomide in paediatric high-grade glioma: a key for combination therapy?
    A C Verschuur
    J Grill
    A Lelouch-Tubiana
    D Couanet
    C Kalifa
    G Vassal
    British Journal of Cancer, 2004, 91 : 425 - 429
  • [7] Temozolomide in paediatric high-grade glioma: a key for combination therapy?
    Verschuur, AC
    Grill, J
    Lelouch-Tubiana, A
    Couanet, D
    Kalifa, C
    Vassal, G
    BRITISH JOURNAL OF CANCER, 2004, 91 (03) : 425 - 429
  • [8] Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma
    Walbert, T.
    Gilbert, M. R.
    Groves, M. D.
    Puduvalli, V. K.
    Yung, W. A.
    Conrad, C. A.
    Bobustuc, G. C.
    Colman, H.
    Bekele, B. N.
    Levin, V. A., Sr.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma
    Walbert, Tobias
    Gilbert, Mark R.
    Groves, Morris D.
    Puduvalli, Vinay K.
    Yung, W. K. Alfred
    Conrad, Charles A.
    Bobustuc, George C.
    Colman, Howard
    Hsu, Sigmund H.
    Bekele, B. Nebiyou
    Qiao, Wei
    Levin, Victor A.
    JOURNAL OF NEURO-ONCOLOGY, 2011, 102 (02) : 273 - 280
  • [10] Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma
    Tobias Walbert
    Mark R. Gilbert
    Morris D. Groves
    Vinay K. Puduvalli
    W. K. Alfred Yung
    Charles A. Conrad
    George C. Bobustuc
    Howard Colman
    Sigmund H. Hsu
    B. Nebiyou Bekele
    Wei Qiao
    Victor A. Levin
    Journal of Neuro-Oncology, 2011, 102 : 273 - 280
12345